Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Haas, A; Uyguner, I; Sochor, GE; Schmut, O; Vidic, B; Faulborn, J.
Non-arteritic anterior ischemic optic neuropathy: long-term results after hemodilution therapy
Klin Monatsbl Augenheilkd. 1994; 205(3):143-146 Doi: 10.1055/s-2008-1045507
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Haas Anton
Co-authors Med Uni Graz
Schmut Otto
Vidic Bertram
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: In patients with nonarteritic anterior ischemic optic neuropathy (AION) we investigated the long-term effect of hemodilution on functional results, recurrence rate in the affected and involvement of the second eye. PATIENTS AND METHODS: In a retrospective study we reviewed 24 patients ranging in age from 62 to 92 years (mean 77 years) with AION. The duration of follow-up was between 8-51 months (mean 24.8 months). All patients received iso- (Hct > 40%) or hypervolemic (Hct < or = 40%) hemodilution over 8-10 days with daily infusion of 10% hydroxyethyl-starch 200/0.5. The hematocrit decreased significant (p < 0.001) from 43.4 +/- 3.8% to 37.8 +/- 3.5% after this 10-day hemodilution treatment. RESULTS: After the longterm follow-up 29.1% of the patients had an improvement of the central vision by two or more lines, 16.7% had a deterioration, 54.2% remained unchanged. The resulting visual acuity was between 0.5-1.0 in 37.5%, between 0.4-0.1 in 41.7% and worse than 0.1 in 20.8%. Neither visual fields nor the VECP were significant changed by hemodilution. After the mean follow-up period of 24.8 months no recurrence occurred in the affected eye and the second eye as never involved. CONCLUSION: Hemodilution therapy has no significant longterm effect on visual acuity and visual fields, but it seems to have a beneficial influence on the recurrence rate in the affected and on the involvement of the second eye.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Aged, 80 and over -
Evoked Potentials, Visual - drug effects
Female - drug effects
Follow-Up Studies - drug effects
Hematocrit - drug effects
Hemodilution - methods
Hetastarch - administration and dosage
Humans - administration and dosage
Ischemia - blood
Long-Term Care - blood
Male - blood
Middle Aged - blood
Optic Nerve - blood supply
Optic Neuritis - blood
Recurrence - blood
Retrospective Studies - blood
Visual Acuity - drug effects
Visual Fields - drug effects

Find related publications in this database (Keywords)
Nonarteritic Anterior Ischemic Optic Neuropathy
Hemodilution
Recurrence
© Med Uni GrazImprint